Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Rating of "Hold" from Analysts

Key Points

• Analyst consensus: 14 analysts give Henry Schein an average rating of "Hold" (1 sell, 7 hold, 6 buy) with a one-year average price target of $87.75.
• Quarterly results and guidance: Henry Schein reported EPS of $1.34 (vs. $1.30 est.) and revenue of $3.44B (vs. $3.34B), and set FY2026 guidance of EPS 5.230–5.370 (analysts average ~5.3).
• Insider activity: Insiders have sold 105,911 shares worth about $8.57M in the past 90 days, and corporate insiders own just 0.89% of the stock.

Shares of Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) have earned an average rating of "Hold" from the fourteen analysts that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and six have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $87.75.

Several analysts have recently commented on the stock. Wells Fargo & Company increased their price target on shares of Henry Schein from $76.00 to $87.00 and gave the company an "equal weight" rating in a research report on Wednesday, February 25th. Citigroup started coverage on shares of Henry Schein in a research report on Wednesday, April 15th. They issued a "buy" rating and a $100.00 price target on the stock. BTIG Research started coverage on shares of Henry Schein in a research note on Thursday, April 16th. They set a "neutral" rating on the stock. Leerink Partners reissued a "market perform" rating on shares of Henry Schein in a research note on Monday, March 9th. Finally, Wall Street Zen downgraded shares of Henry Schein from a "strong-buy" rating to a "buy" rating in a research note on Sunday, April 26th.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Director Kurt P. Kuehn sold 2,844 shares of the firm's stock in a transaction dated Tuesday, March 10th. The stock was sold at an average price of $78.96, for a total value of $224,562.24. Following the sale, the director directly owned 15,420 shares of the company's stock, valued at approximately $1,217,563.20. This trade represents a 15.57% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Mark E. Mlotek sold 5,925 shares of the firm's stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $80.80, for a total value of $478,740.00. Following the completion of the sale, the executive vice president directly owned 80,554 shares in the company, valued at approximately $6,508,763.20. The trade was a 6.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 105,911 shares of company stock valued at $8,574,982. 0.89% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Henry Schein

Large investors have recently bought and sold shares of the stock. CYBER HORNET ETFs LLC purchased a new position in Henry Schein during the second quarter worth approximately $25,000. MUFG Securities EMEA plc purchased a new position in Henry Schein during the second quarter worth approximately $27,000. Flagship Harbor Advisors LLC purchased a new position in Henry Schein during the fourth quarter worth approximately $30,000. Federated Hermes Inc. purchased a new position in shares of Henry Schein in the 4th quarter valued at $32,000. Finally, Los Angeles Capital Management LLC purchased a new position in shares of Henry Schein in the 4th quarter valued at $37,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Trading Up 1.1%

Shares of HSIC opened at $74.59 on Friday. The company has a current ratio of 1.38, a quick ratio of 0.76 and a debt-to-equity ratio of 0.59. The firm's 50-day moving average is $76.59 and its two-hundred day moving average is $74.68. Henry Schein has a twelve month low of $61.94 and a twelve month high of $89.29. The firm has a market capitalization of $8.56 billion, a P/E ratio of 22.81, a PEG ratio of 2.18 and a beta of 0.88.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, February 24th. The company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.04. The company had revenue of $3.44 billion for the quarter, compared to analyst estimates of $3.34 billion. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. The firm's revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.19 earnings per share. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. On average, research analysts predict that Henry Schein will post 5.3 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.